Validation of chemokine receptors as drug targets

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Validation of chemokine receptors as drug targets. / Lüttichau, Hans Rudolf; Schwartz, Thue W.

In: Current Opinion in Drug Discovery & Development, No. 3, no. 5, 2000, p. 610-623.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Lüttichau, HR & Schwartz, TW 2000, 'Validation of chemokine receptors as drug targets', Current Opinion in Drug Discovery & Development, no. 3, no. 5, pp. 610-623.

APA

Lüttichau, H. R., & Schwartz, T. W. (2000). Validation of chemokine receptors as drug targets. Current Opinion in Drug Discovery & Development, (3, no. 5), 610-623.

Vancouver

Lüttichau HR, Schwartz TW. Validation of chemokine receptors as drug targets. Current Opinion in Drug Discovery & Development. 2000;(3, no. 5):610-623.

Author

Lüttichau, Hans Rudolf ; Schwartz, Thue W. / Validation of chemokine receptors as drug targets. In: Current Opinion in Drug Discovery & Development. 2000 ; No. 3, no. 5. pp. 610-623.

Bibtex

@article{a4705cb074c811dbbee902004c4f4f50,
title = "Validation of chemokine receptors as drug targets",
author = "L{\"u}ttichau, {Hans Rudolf} and Schwartz, {Thue W.}",
year = "2000",
language = "English",
pages = "610--623",
journal = "Current Opinion in Drug Discovery and Development",
issn = "1367-6733",
publisher = "Current Drugs Ltd",
number = "3, no. 5",

}

RIS

TY - JOUR

T1 - Validation of chemokine receptors as drug targets

AU - Lüttichau, Hans Rudolf

AU - Schwartz, Thue W.

PY - 2000

Y1 - 2000

M3 - Journal article

SP - 610

EP - 623

JO - Current Opinion in Drug Discovery and Development

JF - Current Opinion in Drug Discovery and Development

SN - 1367-6733

IS - 3, no. 5

ER -

ID: 186013